Cancan Zhou | Hepatic toxicology | Best Research Award

Posted on by Pencis

Prof. Cancan Zhou | Hepatic toxicology  | Best Research Award

Prof. Cancan Zhou, Shanghai Tenth People’s Hospital, China

Prof. Cancan Zhou is a distinguished researcher at the Department of Pharmacy, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, China. He is an active member of the Shanghai Pharmacological Society Clinical Drug Evaluation Committee and the Shanghai Hospital Association Clinical Pharmaceutical Management Committee. Prof. Zhou has led a youth project under the National Natural Science Foundation of China, funded by the Shanghai Sailing Program, and has authored over 10 SCI-indexed papers as the first or corresponding author. Her expertise focuses on hepatic toxicology, drug safety, and advanced pharmacological research.

Profile:

Scopus Profile

📘 EARLY ACADEMIC PURSUITS:

The Department of Pharmacy at Shanghai Tenth People’s Hospital, affiliated with Tongji University School of Medicine, Shanghai, China, serves as a cornerstone for advanced clinical pharmaceutical education and research. With a strong emphasis on evidence-based practices and innovation, the academic foundation was laid through rigorous training in drug evaluation, pharmaceutical management, and patient-centric care. This foundation has enabled significant advancements in the field of clinical pharmacy.

💼 PROFESSIONAL ENDEAVORS:

As a Member of the Shanghai Pharmacological Society Clinical Drug Evaluation Committee and the Shanghai Hospital Association Clinical Pharmaceutical Management Committee, the individual plays a pivotal role in shaping clinical pharmaceutical policies and practices. These roles underscore a dedication to improving healthcare systems, advancing drug evaluation protocols, and ensuring the highest standards of pharmaceutical care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON Hepatic toxicology :

A highlight of this career is the successful leadership of a youth project under the National Natural Science Foundation of China, supported by the prestigious Shanghai Sailing Program. The research primarily focuses on:

  • Clinical Drug Evaluation 🩺
  • Innovative Pharmaceutical Management Strategies 📈
  • Advancing Patient-Centered Therapies 🤝

This work has had a transformative effect on improving drug safety, efficacy, and accessibility in clinical settings.

🌟 IMPACT AND INFLUENCE:

With more than 10 SCI-indexed publications as the first or corresponding author, the individual’s research contributions have significantly influenced both academic discussions and practical applications in the pharmaceutical sciences. These publications have enhanced the understanding of clinical drug evaluation processes and established benchmarks for excellence in research methodologies.

📖 ACADEMIC CITES:

The widespread citation of these publications reflects their impact on the global scientific community. The work has inspired new research, informed clinical guidelines, and contributed to the development of innovative therapeutic strategies. These achievements highlight the individual’s reputation as a thought leader in pharmaceutical sciences.

🔮 LEGACY AND FUTURE CONTRIBUTIONS:

This career reflects a legacy of excellence, blending cutting-edge research with impactful professional service. Moving forward, the focus is expected to center on:

  • Integrating Artificial Intelligence into Drug Evaluation 🤖
  • Developing Sustainable Healthcare Practices 🌱
  • Expanding International Collaborations in Clinical Research 🌍

These contributions aim to enhance healthcare outcomes, streamline pharmaceutical processes, and pave the way for next-generation drug development and management.

💡 OTHER IMPORTANT TOPICS:

🏆 LEADERSHIP IN CLINICAL PHARMACEUTICAL COMMITTEES

Active participation in key committees showcases exemplary leadership and the ability to influence policy decisions that shape the future of clinical pharmacy in Shanghai and beyond.

📈 SUCCESS IN YOUTH PROJECTS

The youth project, supported by competitive funding, highlights the individual’s capacity to lead high-impact research. This success demonstrates both academic merit and the ability to deliver results in fast-evolving scientific domains.

👨‍🏫 MENTORSHIP AND EDUCATION

As part of Tongji University School of Medicine, the individual likely contributes to training the next generation of clinical pharmacists, fostering innovation, and promoting ethical and evidence-based practices.

🌍 VISION FOR GLOBAL PHARMACEUTICAL INTEGRATION

Future aspirations include strengthening cross-border collaborations to harmonize pharmaceutical standards, improve global drug accessibility, and contribute to sustainable healthcare practices worldwide.

✨ CONCLUSION:

The professional journey outlined reflects a remarkable blend of academic excellence, impactful research, and leadership in clinical pharmacy. With a clear vision for future contributions, this profile is set to continue driving innovation, improving patient care, and leaving a lasting legacy in pharmaceutical sciences.

TOP NOTABLE PUBLICATIONS:

STING Signaling Contributes to Methotrexate-Induced Liver Injury by Regulating Ferroptosis in Mice

Authors: Wang, H.-F.; He, Y.-Q.; Ke, Z.; Zhou, C.-C.; Xu, J.-S.

Journal: Ecotoxicology and Environmental Safety

Year: 2024

Natural Products for the Treatment of Chemotherapy-Related Cognitive Impairment and Prospects of Nose-to-Brain Drug Delivery

Authors: He, Y.-Q.; Zhou, C.-C.; Jiang, S.-G.; Tao, X.; Chen, W.-S.

Journal: Frontiers in Pharmacology

Year: 2024

Ursodeoxycholic Acid Alleviates Sepsis-Induced Lung Injury by Blocking PANoptosis via STING Pathway

Authors: He, Y.-Q.; Deng, J.-L.; Zhou, C.-C.; Tao, X.; Chen, W.-S.

Journal: International Immunopharmacology

Year: 2023

Long Survival in a Pancreatic Carcinoma Patient with Multi-Organ Toxicities After Sintilimab Treatment: A Case Report

Authors: Ni, C.-X.; Zhao, Y.; Qian, H.; Li, D.-J.; Xu, Q.

Journal: Frontiers in Pharmacology

Year: 2023

Clinical Features of Omicron SARS-CoV-2 Variants Infection Associated with Co-Infection and ICU-Acquired Infection in ICU Patients

Authors: Li, D.-J.; Zhou, C.-C.; Huang, F.; Shen, F.-M.; Li, Y.-C.

Journal: Frontiers in Public Health

Year: 2023

Zinc Supplementation Ameliorates Sorafenib-Induced Cognitive Impairment Through ROS/JNK Signaling Pathway

Authors: Zhou, C.-C.; He, Y.-Q.; Qiu, Y.-S.; Shen, F.-M.; Li, D.-J.

Journal: Biological Trace Element Research

Year: 2023

Exerkine Fibronectin Type-III Domain-Containing Protein 5/Irisin-Enriched Extracellular Vesicles Delay Vascular Ageing by Increasing SIRT6 Stability

Authors: Chi, C.; Fu, H.; Li, Y.-H.; Li, D.-J.; Wang, P.

Journal: European Heart Journal

Year: 2022

Activating α7nAChR Ameliorates Abdominal Aortic Aneurysm Through Inhibiting Pyroptosis Mediated by NLRP3 Inflammasome

Authors: Fu, H.; Shen, Q.-R.; Zhao, Y.; Liang, G.; Shen, F.-M.

Journal: Acta Pharmacologica Sinica

Year: 2022

Lead Exposure in Developmental Ages Promotes Aβ Accumulation by Disturbing Aβ Transportation in Blood-Cerebrospinal Fluid Barrier/Blood–Brain Barriers and Impairing Aβ Clearance in the Liver

Authors: Zhou, C.-C.; Wang, X.-J.; Li, Z.-C.; Shen, F.-M.; Li, D.-J.

Journal: Biological Trace Element Research

Year: 2022

Abdominal Aortic Aneurysm: Pathological Mechanism and Animal Model

Authors: Fu, H.; Zhou, C.; Li, D.; Shen, F.

Journal: Acta Academiae Medicinae Sinicae

Year: 2022

Yumei Li | Pediatric Cardiology | Best Researcher Award

Posted on by Pencis

Prof.Yumei Li | Pediatric Cardiology | Best Researcher Award

Prof. Yumei Li,  The First Hospital of Jilin University,  China.

Yumei Li is the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. A renowned leader in Pediatric Critical Care Medicine, she founded the largest and most advanced pediatric critical care unit in Jilin Province. With over 31 years of experience, Professor Li has led 50 research projects and published 130 papers, including 45 SCI-indexed articles. She has mentored doctoral students, contributed to eight key textbooks, and secured nearly 4 million yuan in research funding. Her work in pediatric liver transplantation and life support technology has driven innovation and saved countless lives.

Author Profile:

Scopus Profile

Summary of Suitability for Best Researcher Award

Dr. Yumei Li, Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University, is an exemplary candidate for the Best Researcher Award. With over 31 years of experience, Dr. Li has made pioneering contributions in pediatric critical care, particularly in pediatric liver transplantation and extracorporeal life support technologies, transforming clinical care standards in Jilin Province.Her impressive research portfolio includes leading 50 national and provincial projects, securing nearly 4 million yuan in research funding. Dr. Li has published 130 research papers, with 45 indexed in SCI journals, reflecting her significant global impact. Additionally, her academic influence is demonstrated through 16 teaching grants, authorship of 8 major textbooks, and supervision of 21 research scholars (15 graduated, 6 ongoing).

🎓 Education:

Yumei Li holds a doctoral degree in Pediatrics, showcasing her strong academic foundation and commitment to advancing medical knowledge. As a professor and doctoral supervisor, she has dedicated nearly 30 years to pediatric education and research. Her expertise spans pediatric critical care, with significant contributions to clinical advancements and medical education. She has played a key role in developing pediatric textbooks and teaching materials, serving as an editorial board member for several publications. Her passion for education and mentorship has shaped future pediatric specialists, solidifying her reputation as a distinguished educator and leader in the field of Pediatrics.

💼 Professional Experience:

Yumei Li has over 31 years of professional experience in Pediatrics and Pediatric Critical Care Medicine. She currently serves as the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. As the founder of Pediatric Critical Care Medicine in Jilin Province, she has played a pivotal role in developing the region’s most advanced pediatric critical care unit. Her expertise spans pediatric liver transplantation and extracorporeal life support technology. Additionally, she is a professor, doctoral supervisor, and an influential contributor to medical education and clinical innovation

🌍Research Contributions:

Yumei Li has over 31 years of professional experience in Pediatrics and Pediatric Critical Care Medicine. She currently serves as the Executive Director of the Children’s Medical Center and Director of the Pediatric Intensive Care Unit at the First Hospital of Jilin University. As the founder of Pediatric Critical Care Medicine in Jilin Province, she has played a pivotal role in developing the region’s most advanced pediatric critical care unit. Her expertise spans pediatric liver transplantation and extracorporeal life support technology. Additionally, she is a professor, doctoral supervisor, and an influential contributor to medical education and clinical innovation.

🥇Award and Honors:

Yumei Li has received 16 awards and honors recognizing her outstanding contributions to pediatric critical care and medical research. As the founder of the Pediatric Critical Care Medicine Department in Jilin Province, she has been honored for advancing pediatric liver transplantation and extracorporeal life support technology. Her leadership and dedication have earned her numerous accolades for excellence in clinical practice, teaching, and research. Professor Li’s impactful contributions include leading 50 research projects and publishing 130 papers, which have significantly influenced pediatric healthcare. These achievements highlight her commitment to innovation, education, and improving patient outcomes, solidifying her reputation as a distinguished medical professional.

Conclusion:

Professor Yumei Li has made outstanding contributions to the field of Pediatric Critical Care Medicine through her exceptional leadership, research, and clinical expertise. With over 31 years of experience, she has established the largest pediatric critical care unit in Jilin Province, significantly advancing pediatric liver transplantation and extracorporeal life support technologies. Her impressive research portfolio, including 50 funded projects and 130 publications with 45 SCI-indexed papers, reflects her commitment to innovation and academic excellence. Professor Li’s dedication to education, mentorship, and technological advancements highlights her as a pioneering figure, making her a deserving candidate for the Best Researcher Award.

📚Publication Top Notes:

📄 “Comprehensive review of indicators and techniques for optical mapping of intracellular calcium ions” – Cerebral Cortex, 2024, 34(8), bhae346 | Cited: 0

🧒 “Children with severe neurological symptoms associated with SARS-CoV-2 infection during Omicron pandemic in China” – Pediatric Research, 2024, 95(4), pp. 1088–1094 | Cited: 0

🏥 “Association between BNP and all-cause mortality in critically ill children: a cohort study” – Pediatric Research, 2024 | Cited: 0

🦠 “Biliary atresia: the role of gut microbiome, and microbial metabolites” – Frontiers in Cellular and Infection Microbiology, 2024, 14, 1411843 | Cited: 0

🍊 “Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications” – Frontiers in Pharmacology, 2024, 15, 1354809 | Cited: 4

🚨 “Demographics and Clinical Characteristics Assessment of Severe Acute Toxic Ingestions in Pediatric Patients: A Single-Center Study in Jilin Province of China” – Pediatric Emergency Care, 2023, 39(12), pp. 957–962 | Cited: 0

🧪 “Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor” – Materials Today Bio, 2023, 23, 100796 | Cited: 6

🧠 “Contactin-associated protein-like 2 antibody-associated autoimmune encephalitis in children: case reports and systematic review of literature” – Acta Neurologica Belgica, 2023, 123(5), pp. 1663–1678 | Cited: 0

⚛️ “One-Component Artificial Gustatory System Based on Hydrogen-Bond Organic Framework for Discrimination of Versatile Analytes” – Advanced Functional Materials, 2023, 33(24), 2300091 | Cited: 22

🔄 “Therapeutic plasma exchange in anti-N-methyl-D-aspartate receptor encephalitis” – Therapeutic Apheresis and Dialysis, 2023, 27(2), pp. 197–206 | Cited: 0